The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis

Neurochemical Research

Volumn 36, Issue 6, 2011, Pages 1012-1016

  Miller, Elzbieta ^a   Mrowicka, Małgorzata ^b   Saluk Juszczak, Joanna ^c   Ireneusz, Majsterek ^b  

^a III General Hospital in Lodz   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c UNIVERSITY OF LODZ   (Poland)

Author keywords

Isoprostanes; Lipid peroxidation; Marker; Multiple sclerosis; Oxidative stress; Total antioxidative status

Indexed keywords

BIOLOGICAL MARKER; ISOPROSTANE DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; IN VIVO STUDY; LIPID PEROXIDATION; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS; URINE LEVEL;

ADULT; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; ISOPROSTANES; LIPID PEROXIDATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OXIDATIVE STRESS;

EID: 79955696219     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-011-0442-1     Document Type: Article

References (21)

1. Bielekova B, Martin R (2004) Development of biomarkers in multiple sclerosis. Brain 127:1463-1478 (Pubitemid 38899400)
2. Pokryszko-Dragan A, Gruszka E, Bilińska M (2008) Secondary progressive multiple sclerosis-clinical course and potential predictive factors. Neurol Neurochir Pol 42:6-11 (Pubitemid 351493447)
3. Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis. The need for the effective antioxidant therapy. J Neurol 25:261-268 (Pubitemid 38387142)
4. Gonsette R (2008) Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? Mult Scler 14:22-34
5. Miller E (2011) Multiple sclerosis. In: Shamim I Ahmad. Neurodegenerative diseases. Springer Lands Bioscience. [in press]
6. Adibhatla Muralikrishna R, Hatcher JF (2008) Altered lipid metabolism in brain injury and disorders. Subcell Biochem 49:241-268
7. Miller E, Mrowicka M, Malinowska et al (2010) Effects of whole body cryotherapy on total antioxidative status and activities of antioxidative enzymes in blood of patients with multiple sclerosis. J Med Invest 57:168-173
8. Miller E, Mrowicka M, Malinowska et al (2010) Effects of whole body cryotherapy on oxidative stress in multiple sclerosis patients. J Therm Biol 35:406-410
9. Choi IY, Lee SP, Denney D et al. (2010) Lower levels of gluthatione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3T. Mult Scler [Epub ahead of print]
10. Mattsson N, Haghighi S, Andersen O et al (2007) Elevated cerebrospinal fluid F2- isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients. Neurosci Lett 13:233-236
11. Awe SO, Opere CA, Harris LC et al (2000) Effects of isoprostanes on sympathetic neurotransmission in the human isolated iris-ciliary body. Neurochem Res 25:491-496 (Pubitemid 30317681)
12. Lubin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis results of an international survey. National Multiple Sclerosis Society USA Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907-911
13. Basu S (2004) Isoprostanes: novel bioactive products of lipid peroxidation. Free Radic Res 38:105-122
14. Greco A, Minghetti L, Levi G (2000) Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases. Neurochem Res 25:1357-1364
15. Morrow JD (2006) The isoprostanes-unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr Pharm 12:895-902
16. Koch J, Mostest AV, Arutjungan M et al (2007) Plasma lipid peroxidation and progression of disability in mutiple sclerosis. J Europ Neur 14:529-533
17. Onufriev MV (2010) Nitrosative stress in the brain: autoantibodies to nitrotyrosine in liquor as a potential marker. Neurochem J 4:228-234
18. Wachowicz B, Rywaniak JZ, Nowak P (2008) Apoptic matkers in human blood platelets treated with peroxynitrite. Platelets 19:624-635
19. Choi IY, Lee SP, Denney D et al. (2010) Lower levels of gluthatione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3T. Mult Scler [Epub ahead of print]
20. Miller E, Mrowicka M, Malinowska K et al. (2010) Effects of whole body cryotherapy on a total antioxidative status and activity of antioxidant enzymes in blood of depressive multiple sclerosis patients. World J biol Psychiatry [Epub a head of print]
21. Besler HT, Comoglu S, Okcu Z (2002) Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr Neurosci 5:215-220 (Pubitemid 34568217)